DE60239753D1 - Impfstoff gegen infektiöses lachsanämievirus - Google Patents

Impfstoff gegen infektiöses lachsanämievirus

Info

Publication number
DE60239753D1
DE60239753D1 DE60239753T DE60239753T DE60239753D1 DE 60239753 D1 DE60239753 D1 DE 60239753D1 DE 60239753 T DE60239753 T DE 60239753T DE 60239753 T DE60239753 T DE 60239753T DE 60239753 D1 DE60239753 D1 DE 60239753D1
Authority
DE
Germany
Prior art keywords
virus
lachsanemia
against infectious
vaccinate against
antigenic polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60239753T
Other languages
English (en)
Inventor
Stephane Villoing
Erik Biering
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International BV filed Critical Intervet International BV
Application granted granted Critical
Publication of DE60239753D1 publication Critical patent/DE60239753D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60239753T 2001-10-19 2002-10-16 Impfstoff gegen infektiöses lachsanämievirus Expired - Lifetime DE60239753D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01203951 2001-10-19
PCT/EP2002/011552 WO2003035680A1 (en) 2001-10-19 2002-10-16 Infectious salmon anaemia virus vaccine

Publications (1)

Publication Number Publication Date
DE60239753D1 true DE60239753D1 (de) 2011-05-26

Family

ID=8181091

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60239753T Expired - Lifetime DE60239753D1 (de) 2001-10-19 2002-10-16 Impfstoff gegen infektiöses lachsanämievirus

Country Status (7)

Country Link
US (1) US7279167B2 (de)
EP (1) EP1440086B1 (de)
AT (1) ATE505482T1 (de)
CA (1) CA2464338C (de)
DE (1) DE60239753D1 (de)
NO (1) NO335085B1 (de)
WO (1) WO2003035680A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7578796B2 (en) * 2004-10-22 2009-08-25 General Patent Llc Method of shockwave treating fish and shellfish
JP2010514412A (ja) 2006-12-22 2010-05-06 ソリューシオネス バイオテクノロジカス イノヴァシオン リミターダ Ｄｎａ魚ワクチン
US8697085B2 (en) * 2011-06-17 2014-04-15 University Of Tennessee Research Foundation Group A Streptococcus multivalent vaccine
EP2753686A4 (de) * 2011-09-09 2015-06-03 Advanced Bionutrition Corp Bivalenter ipnv-isav-impfstoff unter verwendung einer virusähnlichen partikelplattform und verwendungsverfahren dafür
CN106749647A (zh) * 2016-02-18 2017-05-31 北京市农林科学院 鲑鳟鱼ihnv单克隆抗体及检测试剂盒
NO344698B1 (en) * 2018-06-15 2020-03-09 Patogen As Novel fish virus
CN109136200B (zh) * 2018-09-20 2022-02-18 中国水产科学研究院黑龙江水产研究所 一种重组传染性造血器官坏死病毒及其构建方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60017229D1 (de) 1999-10-18 2005-02-10 Akzo Nobel Nv DNA kodierend für das Strukturalprotein-1 vom infektiösen Lachs Anämie Virus und ihre Verwendungen
WO2002079231A2 (en) 2001-03-30 2002-10-10 Microtek International (1998) Ltd. Nucleic acids encoding isav polypeptides

Also Published As

Publication number Publication date
CA2464338C (en) 2014-12-02
NO335085B1 (no) 2014-09-08
EP1440086B1 (de) 2011-04-13
NO20041564L (no) 2004-04-16
ATE505482T1 (de) 2011-04-15
US20040253580A1 (en) 2004-12-16
WO2003035680A1 (en) 2003-05-01
EP1440086A1 (de) 2004-07-28
US7279167B2 (en) 2007-10-09
CA2464338A1 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
CY1122505T1 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις για την θεραπευτικη αγωγη της παθολογιας του crohn
ATE528016T1 (de) Virusähnliche partikel als paramyxovirus- impfstoffe
EA200501524A1 (ru) Антитела против амилоида, композиции, способы и применения
DK1881845T3 (da) Nipah-virusvacciner
DE60144240D1 (de) Zusammensetzung mit immunogenen mikroteilchen
CY1110793T1 (el) Εμβολιο φυματιωσης με βελτιωμενη αποτελεσματικοτητα
ATE426412T1 (de) Adjuvante influenza-vakzine
CY1120430T1 (el) Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων
PT1951300E (pt) Modificação do equilíbrio de th1/th2 em vacinas da influenza fragmentadas com adjuvantes
ATE517184T1 (de) Hcv ns3/4a kodierende nukleinsäure
ATE473236T1 (de) Antigene von piscirickettsia salmonis und deren verwendung
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
DE60239753D1 (de) Impfstoff gegen infektiöses lachsanämievirus
DE60231821D1 (de) Rekombinante tollwut-vakzine und verfahren zu ihrer herstellung und verwendung
DE602004023196D1 (de) Vakzine zusammensetzung zur impfung von hunden gegen infektiöse atemwegserkrankung bei hunden (cird)
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
AR019785A1 (es) Pestivirus no diseminantes
NO20060395L (no) Antigenholdig dyrevaksine
BR0013574A (pt) Antìgeno vacina de moraxella
ATE374622T1 (de) Genetische impstoffe mit adjuvans
WO2002079231A3 (en) Nucleic acids encoding isav polypeptides
DE69534280D1 (de) Orale impfstoffe gegen yersinia pestis infektionen
DE60100879D1 (de) Helicobacter felis Impfstoff
ES2172482B1 (es) Adicion de la patente es200100402 "vacuna para la proteccion de perros frente a la leishmania".